scout
Opinion|Videos|December 8, 2023

Evaluating the Impact of Elacestrant Use in Clinical Practice for Patients With ER+/HER2-Metastasized Breast Cancer

Identifying the impact of elacestrant in clinical practice for patients with ER+/HER2- metastatic breast cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME